GW24-e1001 Effects of advanced glycation end products on function and angiogenesis of adipose tissue-derived stem cells and protective effects of Danhong injection. (1st October 2013)
- Record Type:
- Journal Article
- Title:
- GW24-e1001 Effects of advanced glycation end products on function and angiogenesis of adipose tissue-derived stem cells and protective effects of Danhong injection. (1st October 2013)
- Main Title:
- GW24-e1001 Effects of advanced glycation end products on function and angiogenesis of adipose tissue-derived stem cells and protective effects of Danhong injection
- Authors:
- Feng, Wu
Zhiqing, He
Ruizhen, Ji
Xin, Wang
Zonggui, Wu
Chun, Liang - Abstract:
- Abstract : Objectives: To investigate the effects of N ε -(carboxymethyl) Lysine albumin (CMLs), a primary advanced glycation end products isoform in diabetic body, on function and angiogenesis of adipose tissue-derived stem cells (ADSCs) and protective effects of Danhong injection. Methods: ADSCs were obtained by combination with enzymatically digestion and centrifugation, and then were identified to observe cultured cells' morphology and induce differentiation towards adipocytes, osteocytes and chondrocytes. The cells were exposed to 5 different interventions respectively for 24 hours, including PBS, 60 μg/mlBSA, 60 μg/ml CML-BSA, 0.5 ul/ml DH and 60 μg/mlCML-BSA + 0.5 ul/ml DH. The proliferation capability of such cells were evaluated using WST-1 assay, migration ability were explored by transwell assay, the apoptoticrates were investigated by FCM, secreted VEGF in culture supernatant were measured by ELISA, and angiogenesis of such cells was observed in matrigel invitro. Results: Compared with the BSA control group, proliferation, migration and secretion capability of ADSCs were inhibited by stimuli with CML-BSA (n = 6, P < 0.05), but the apoptosis of such cells were promoted. Finally, angiogenesis of ADSCs was significantly inhibited. DH (0.5 ul/ml) could promote proliferation, migration and secretion capability but inhibit apoptosis of ADSCs (n = 6, P < 0.05) vs PBS, and furthermore partiallyreverse the negative effects of CML-BSA (60 μg/ml) on ADSCs (n = 6, P < 0.05).Abstract : Objectives: To investigate the effects of N ε -(carboxymethyl) Lysine albumin (CMLs), a primary advanced glycation end products isoform in diabetic body, on function and angiogenesis of adipose tissue-derived stem cells (ADSCs) and protective effects of Danhong injection. Methods: ADSCs were obtained by combination with enzymatically digestion and centrifugation, and then were identified to observe cultured cells' morphology and induce differentiation towards adipocytes, osteocytes and chondrocytes. The cells were exposed to 5 different interventions respectively for 24 hours, including PBS, 60 μg/mlBSA, 60 μg/ml CML-BSA, 0.5 ul/ml DH and 60 μg/mlCML-BSA + 0.5 ul/ml DH. The proliferation capability of such cells were evaluated using WST-1 assay, migration ability were explored by transwell assay, the apoptoticrates were investigated by FCM, secreted VEGF in culture supernatant were measured by ELISA, and angiogenesis of such cells was observed in matrigel invitro. Results: Compared with the BSA control group, proliferation, migration and secretion capability of ADSCs were inhibited by stimuli with CML-BSA (n = 6, P < 0.05), but the apoptosis of such cells were promoted. Finally, angiogenesis of ADSCs was significantly inhibited. DH (0.5 ul/ml) could promote proliferation, migration and secretion capability but inhibit apoptosis of ADSCs (n = 6, P < 0.05) vs PBS, and furthermore partiallyreverse the negative effects of CML-BSA (60 μg/ml) on ADSCs (n = 6, P < 0.05). Conclusions: CMLs could significantly inhibit proliferation, migration, but promote apoptosis and reduce VEGF expression and secretion of ADSCs. DH injection would partially reverses the negative effects of CMLs. CMLs could significantly inhibit angiogenesis of ADSCs, which would partially reversed by DH injection. … (more)
- Is Part Of:
- Heart. Volume 99(2013)Supplement 3
- Journal:
- Heart
- Issue:
- Volume 99(2013)Supplement 3
- Issue Display:
- Volume 99, Issue 3 (2013)
- Year:
- 2013
- Volume:
- 99
- Issue:
- 3
- Issue Sort Value:
- 2013-0099-0003-0000
- Page Start:
- A30
- Page End:
- A30
- Publication Date:
- 2013-10-01
- Subjects:
- Heart -- Diseases -- Treatment -- Periodicals
Cardiology -- Periodicals
616.12 - Journal URLs:
- http://www.bmj.com/archive ↗
http://heart.bmj.com ↗
http://www.heartjnl.com ↗ - DOI:
- 10.1136/heartjnl-2013-304613.78 ↗
- Languages:
- English
- ISSNs:
- 1355-6037
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25835.xml